Quantum biopharma announces very promising results from the massachusetts general hospital scientists on the novel positron emission tomography (pet) tracer used to detect and monitor demyelination in multiple sclerosis patients

Ongoing joint clinical study could pave the way for testing efficacy of quantum's investigational ms drug, lucid-21-302 ongoing joint clinical study could pave the way for testing efficacy of quantum's investigational ms drug, lucid-21-302
QNTM Ratings Summary
QNTM Quant Ranking